{"pmid":32467751,"pmcid":"PMC7243827","title":"The effects of the COVID-19 pandemic on oncological surgery.","text":["The effects of the COVID-19 pandemic on oncological surgery.","The COVID-19 global pandemic is changing the practice of oncologic surgery. Accustomed to fighting cancer with all available means, surgeons are now being asked to delay treatment or make use of alternate strategies to conserve resources. Telemedicine is being widely employed. We present our thoughts on this topic and where we might be in the next several months.","J Surg Case Rep","Kling, Sarah M","Philp, Matthew M","32467751"],"abstract":["The COVID-19 global pandemic is changing the practice of oncologic surgery. Accustomed to fighting cancer with all available means, surgeons are now being asked to delay treatment or make use of alternate strategies to conserve resources. Telemedicine is being widely employed. We present our thoughts on this topic and where we might be in the next several months."],"journal":"J Surg Case Rep","authors":["Kling, Sarah M","Philp, Matthew M"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467751","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/jscr/rjaa157","topics":["Prevention"],"weight":1,"_version_":1668420887156621312,"score":9.490897,"similar":[{"pmid":32445315,"title":"Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.","text":["Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.","The Corona Virus Disease-2019 (COVID-19), one of the most devastating pandemics ever, has left thousands of cancer patients to their fate. The future course of this pandemic is still an enigma, but health care services are expected to resume soon in a phased manner. This might be a long drawn process and we need to have policies in place, to be able to fight both, the SARS-CoV-2 virus and cancer, simultaneously, and emerge triumphant. An extensive literature search for impact of delay in management of various urological malignancies was carried out. Expert opinions were sought wherever there was paucity of evidence, in order to reach a consensus and come up with recommendations for directing uro-oncology services in the times of COVID-19. The panel recommends deferring treatment of patients with renal cell carcinoma by 3 to 6 months, except for those with ongoing hematuria and/or inferior vena cava thrombus, which warrant immediate surgery. Metastatic renal cell cancers should be started on targeted therapy. Low grade non-muscle invasive bladder cancers can be kept on active surveillance while high risk non-muscle invasive bladder cancers and muscle invasive bladder cancers should be treated within 3 months. Neoadjuvant chemotherapy should be avoided. Management of low and intermediate risk prostate cancer can be deferred for 3 to 6months while high risk prostate cancer patients can be initiated on neoadjuvant androgen deprivation therapy. Patients with testicular tumors should undergo high inguinal orchiectomy and be treated according to stage without delay, with stage I patients being offered surveillance. Penile cancers should undergo penectomy, while clinically negative groins can be kept on surveillance. Neoadjuvant chemotherapy should be avoided and adjuvant therapy should be deferred. We need to tailor our treatment strategies to the prevailing present conditions, so as to fight and defeat both, the SARS-CoV-2 virus and cancer. Protection of health care workers, judicious use of available resources, and a rational and balanced outlook towards different malignancies is the need of the hour.","Indian J Cancer","Narain, Tushar A","Gautam, Gagan","Seth, Amlesh","Panwar, Vikas K","Rawal, Sudhir","Dhar, Puneet","Talwar, Harkirat S","Singh, Amitabh","Jaipuria, Jiten","Mittal, Ankur","32445315"],"abstract":["The Corona Virus Disease-2019 (COVID-19), one of the most devastating pandemics ever, has left thousands of cancer patients to their fate. The future course of this pandemic is still an enigma, but health care services are expected to resume soon in a phased manner. This might be a long drawn process and we need to have policies in place, to be able to fight both, the SARS-CoV-2 virus and cancer, simultaneously, and emerge triumphant. An extensive literature search for impact of delay in management of various urological malignancies was carried out. Expert opinions were sought wherever there was paucity of evidence, in order to reach a consensus and come up with recommendations for directing uro-oncology services in the times of COVID-19. The panel recommends deferring treatment of patients with renal cell carcinoma by 3 to 6 months, except for those with ongoing hematuria and/or inferior vena cava thrombus, which warrant immediate surgery. Metastatic renal cell cancers should be started on targeted therapy. Low grade non-muscle invasive bladder cancers can be kept on active surveillance while high risk non-muscle invasive bladder cancers and muscle invasive bladder cancers should be treated within 3 months. Neoadjuvant chemotherapy should be avoided. Management of low and intermediate risk prostate cancer can be deferred for 3 to 6months while high risk prostate cancer patients can be initiated on neoadjuvant androgen deprivation therapy. Patients with testicular tumors should undergo high inguinal orchiectomy and be treated according to stage without delay, with stage I patients being offered surveillance. Penile cancers should undergo penectomy, while clinically negative groins can be kept on surveillance. Neoadjuvant chemotherapy should be avoided and adjuvant therapy should be deferred. We need to tailor our treatment strategies to the prevailing present conditions, so as to fight and defeat both, the SARS-CoV-2 virus and cancer. Protection of health care workers, judicious use of available resources, and a rational and balanced outlook towards different malignancies is the need of the hour."],"journal":"Indian J Cancer","authors":["Narain, Tushar A","Gautam, Gagan","Seth, Amlesh","Panwar, Vikas K","Rawal, Sudhir","Dhar, Puneet","Talwar, Harkirat S","Singh, Amitabh","Jaipuria, Jiten","Mittal, Ankur"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445315","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.4103/ijc.IJC_356_20","keywords":["bladder cancer","covid-19","cancer","kindey cancer","open surgery","penile cancer","prostate cancer","robotic surgery","testicular tumor","urooncology"],"locations":["Indian"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1667600475950678016,"score":102.84054},{"pmid":32342541,"title":"Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","text":["Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.","BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability.","Head Neck","Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y","32342541"],"abstract":["BACKGROUND: COVID-19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of healthcare personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging Head and Neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease-specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for HNC patients appropriately allocate resources during a healthcare crisis, such as the COVID-19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability."],"journal":"Head Neck","authors":["Head, Anderson","Maniakas, Anastasios","Jozaghi, Yelda","Zafereo, Mark E","Sturgis, Erich M","Su, Shirley Y","Gillenwater, Ann M","Gidley, Paul W","Lewis, Carol M","Diaz, Eduardo Jr","Goepfert, Ryan P","Kupferman, Michael E","Gross, Neil D","Hessel, Amy C","Pytynia, Kristen B","Nader, Marc-Elie","Wang, Jennifer R","Lango, Miriam N","Kiong, Kimberley L","Guo, Theresa","Zhao, Xiao","Yao, Christopher M K L","Appelbaum, Eric","Alpard, Jennifer","Garcia, Jose A","Terry, Shawn","Flynn, Jill E","Bauer, Sarah","Fournier, Danielle","Burgess, Courtlyn G","Wideman, Cayla","Johnston, Matthew","You, Chenxi","De Luna, Rolando","Joseph, Liza","Diersing, Julia","Prescott, Kaitlin","Heiberger, Katherine","Mugartegui, Lilian","Rodriguez, Jessica","Zendehdel, Sara","Sellers, Justin","Friddell, Rebekah A","Thomas, Ajay","Khanjae, Sonam J","Schwarzlose, Katherine B","Chambers, Mark S","Hofstede, Theresa M","Cardoso, Richard C","Aponte Wesson, Ruth","Won, Alex","Otun, Adegbenga O","Gombos, Dan S","Al-Zubidi, Nagham","Hutcheson, Katherine A","Gunn, G Brandon","Rosenthal, David I","Gillison, Maura L","Ferrarotto, Renata","Weber, Randal S","Hanna, Ehab Y","Myers, Jeffrey N","Lai, Stephen Y"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342541","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1002/hed.26206","keywords":["sars-cov2","oncology","otolaryngology"],"topics":["Prevention"],"weight":1,"_version_":1666138495125553152,"score":100.30917},{"pmid":32488866,"title":"Flattening the curve in oncologic surgery: Impact of Covid-19 on surgery at tertiary care cancer center.","text":["Flattening the curve in oncologic surgery: Impact of Covid-19 on surgery at tertiary care cancer center.","INTRODUCTION: Covid-19 has ushered in drastic changes to the healthcare system in order to \"flatten the curve\"; in particular, surgical operations that can consume vital, limited resources, not to mention the risk to staff, anesthesiologists, and surgeons. However, under unique circumstances with diligent preparation, vital oncologic operations can be performed safely. METHODS: Prospective comparison of surgical cases during the pandemic from December 2019 to May 2020 to the correlating time frame from December 2018 to May 2019. RESULTS: A significant decline in case volume was not appreciated until the United States declared a national state of emergency, allowing patients with cancer to continue to undergo curative tumor resection until then (428.3 +/- 51.5 vs 166.6 +/- 59.8 cases/week; P < .001). The decrease was consistent with the mean case volume during the holidays (213.8 +/- 76.8 vs 166.6 +/- 59.8 case/week; P = .648). Evaluation of surgical subspecialties demonstrated a significant decrease for all subspecialties with the greatest decline in sarcoma (P = .002) and endocrine (P = .001) surgeries, while vascular (P = .004) and thoracic (P = .011) surgeries had the least. CONCLUSIONS: The novel coronavirus has drastically reduced oncologic operations, but with proper evaluation of patients and allocation of resources, surgery can be performed safely without compromising the aim to flatten the curve and control the coronavirus pandemic.","J Surg Oncol","Chang, Edward I","Liu, Jesse Jun","32488866"],"abstract":["INTRODUCTION: Covid-19 has ushered in drastic changes to the healthcare system in order to \"flatten the curve\"; in particular, surgical operations that can consume vital, limited resources, not to mention the risk to staff, anesthesiologists, and surgeons. However, under unique circumstances with diligent preparation, vital oncologic operations can be performed safely. METHODS: Prospective comparison of surgical cases during the pandemic from December 2019 to May 2020 to the correlating time frame from December 2018 to May 2019. RESULTS: A significant decline in case volume was not appreciated until the United States declared a national state of emergency, allowing patients with cancer to continue to undergo curative tumor resection until then (428.3 +/- 51.5 vs 166.6 +/- 59.8 cases/week; P < .001). The decrease was consistent with the mean case volume during the holidays (213.8 +/- 76.8 vs 166.6 +/- 59.8 case/week; P = .648). Evaluation of surgical subspecialties demonstrated a significant decrease for all subspecialties with the greatest decline in sarcoma (P = .002) and endocrine (P = .001) surgeries, while vascular (P = .004) and thoracic (P = .011) surgeries had the least. CONCLUSIONS: The novel coronavirus has drastically reduced oncologic operations, but with proper evaluation of patients and allocation of resources, surgery can be performed safely without compromising the aim to flatten the curve and control the coronavirus pandemic."],"journal":"J Surg Oncol","authors":["Chang, Edward I","Liu, Jesse Jun"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32488866","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jso.26056","keywords":["covid-19 and oncologic surgery","coronavirus pandemic"],"locations":["United States","thoracic"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1668892169371385856,"score":99.20812},{"pmid":32298036,"title":"Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","text":["Framework for prioritizing head and neck surgery during the COVID-19 pandemic.","The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing.","Head Neck","Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B","32298036"],"abstract":["The COVID-19 pandemic has placed an extraordinary demand on the United States health care system. Many institutions have canceled elective and non-urgent procedures to conserve resources and limit exposure. While operational definitions of elective and urgent categories exist, there is a degree of surgeon judgment in designation. In the present commentary, we provide a framework for prioritizing head and neck surgery during the pandemic. Unique considerations for the head and neck patient are examined including risk to the oncology patient, outcomes following delay in head and neck cancer therapy, and risk of transmission during otolaryngologic surgery. Our case prioritization criteria consist of four categories: urgent-proceed with surgery, less urgent-consider postpone > 30 days, less urgent-consider postpone 30 to 90 days, and case-by-case basis. Finally, we discuss our preoperative clinical pathway for transmission mitigation including defining low-risk and high-risk surgery for transmission and role of preoperative COVID-19 testing."],"journal":"Head Neck","authors":["Topf, Michael C","Shenson, Jared A","Holsinger, F Christopher","Wald, Samuel H","Cianfichi, Lisa J","Rosenthal, Eben L","Sunwoo, John B"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32298036","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/hed.26184","keywords":["covid-19","sars-cov-2","clinical practice guidelines","head and neck cancer","surgical oncology"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138493331439616,"score":99.09283},{"pmid":32340542,"title":"A Commentary on the Challenges of Telemedicine for Head and Neck Oncologic Patients during COVID-19.","text":["A Commentary on the Challenges of Telemedicine for Head and Neck Oncologic Patients during COVID-19.","The COVID-19 pandemic is an unprecedented and historic event that presents unique challenges to patient care to medical providers worldwide. The pandemic and the ensuing rapid changes to medical practice have particularly affected head and neck cancer surgeons and their patients. In an effort to balance the needs of our patients with the risks to patient and staff safety, we have been tasked with finding alternatives to the traditional office visit. In this commentary, we discuss how telemedicine can be incorporated into the head and neck surgery practice, the challenges that we have faced, and the dilemmas with which we have dealt in our efforts to fulfill the ongoing need for care of this unique patient population.","Otolaryngol Head Neck Surg","Triantafillou, Vasiliki","Rajasekaran, Karthik","32340542"],"abstract":["The COVID-19 pandemic is an unprecedented and historic event that presents unique challenges to patient care to medical providers worldwide. The pandemic and the ensuing rapid changes to medical practice have particularly affected head and neck cancer surgeons and their patients. In an effort to balance the needs of our patients with the risks to patient and staff safety, we have been tasked with finding alternatives to the traditional office visit. In this commentary, we discuss how telemedicine can be incorporated into the head and neck surgery practice, the challenges that we have faced, and the dilemmas with which we have dealt in our efforts to fulfill the ongoing need for care of this unique patient population."],"journal":"Otolaryngol Head Neck Surg","authors":["Triantafillou, Vasiliki","Rajasekaran, Karthik"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340542","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/0194599820923622","keywords":["covid-19","cancer","head and neck","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138495117164544,"score":96.55038}]}